Related Experiment Video
Updated: Aug 18, 2025

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
Published on: September 20, 2019
Targeting epithelial cell-derived TWIST1 alleviates allergic asthma
Huanping Zhang1, Yanfen Wang2, Xiaoxue Chen1
1Department of Allergy Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
The interaction between TWIST1 and RAS drives T Helper 2 (Th2) polarization in allergic asthma by increasing IL-33. Inhibiting TWIST1 or RAS can prevent asthma development.
Area of Science:
- Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- T Helper 2 (Th2) cell bias is crucial in allergic asthma pathogenesis.
- The mechanisms maintaining Th2 bias in local airway tissues are not fully understood.
- Interleukin-33 (IL-33) is essential for Th2 polarization, and TWIST1 regulates cellular functions, while aberrant RAS activation sustains cellular activities.
Purpose of the Study:
- To investigate the role of TWIST1 and RAS activation interaction in inducing and maintaining Th2 polarization in allergic asthma.
- To explore the association between TWIST1, RAS, and IL-33 expression in airway epithelial cells (AECs) of asthma patients.
Main Methods:
- Isolation of airway epithelial cells (AECs) from broncho-alveolar lavage fluids of asthma patients.
- RNA sequencing to identify mediators involved in IL-33 over-expression.
- Establishment of a mouse model to assess the roles of TWIST1 and RAS in allergic asthma development.
Main Results:
- Strong TWIST1 expression in asthma patients correlated positively with asthmatic responses.
- TWIST1 promoted IL-33 expression in AECs, and Twist1-deficient AEC-carrying mice failed to induce Th2 polarization.
- TWIST1 expression in AECs was positively associated with RAS activation in asthma patients.
- The interaction between RAS and TWIST1 in AECs sustained airway allergic inflammation.
- Inhibition of TWIST1 or RAS prevented experimental asthma-like inflammation in mice.
Conclusions:
- The interaction between TWIST1 and RAS induces and maintains IL-33 expression in AECs, facilitating allergic airway inflammation.
- Targeting the TWIST1-RAS interaction offers a potential therapeutic strategy for allergic asthma.
More Related Videos
12:08Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
Published on: March 10, 2016
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Allergic Reactions